Genotoxicity evaluation of food additive titanium dioxide using a battery of standard in vivo tests
Chunlai Liang,Xiaopeng Zhang,Jin Fang,Nana Sun,Haibo Liu,Yongquan Feng,Huali Wang,Zhou Yu,Xudong Jia,Chunlai liang
DOI: https://doi.org/10.1016/j.yrtph.2024.105586
IF: 3.598
2024-02-01
Regulatory Toxicology and Pharmacology
Abstract:The increasing use of titanium dioxide (TiO<sub>2</sub>) nanoparticles (NPs) has raised concern about the safety of food additive TiO<sub>2</sub>. TiO<sub>2</sub> has been considered no longer safe by EFSA due to concerns over genotoxicity, however, there are conflicting opinions upon the safety of TiO<sub>2</sub> as a food additive, and the number of in vivo genotoxicity studies conducted on food additive TiO<sub>2</sub> was limited. In order to investigate the potential genotoxicity of food additive TiO<sub>2</sub>, we evaluated the genotoxicity of a commercial food additive TiO<sub>2</sub> (average size of 135.54 ± 41.01 nm, range from 60.83 to 230.16 nm, NPs account for 30% by number) using a battery of standard in vivo tests, including mammalian erythrocyte micronucleus test, mammalian bone marrow chromosomal aberration test and in vivo mammalian alkaline comet test. After 15 days of consecutive intragastric administration at doses of 250, 500, and 1000 mg/kgBW, food additive TiO<sub>2</sub> neither increased the frequencies of bone marrow micronuclei or chromosomal aberration in mice, nor induced DNA strand breakage in rat liver cells. These results indicate that under the condition of this study, food additive TiO<sub>2</sub> does not have genotoxic potential although it contains a fraction of NPs.
pharmacology & pharmacy,toxicology,medicine, legal